NovoCure's total assets for Q2 2026 were $795.19M, an increase of 0.92% from the previous quarter. MX:NVCRN total liabilities were $457.10M for the fiscal quarter, a -0.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.